{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:31:13Z","timestamp":1792791073133,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.021","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T15:00:51Z","timestamp":1479999651000},"page":"809-815","source":"Crossref","is-referenced-by-count":56,"title":["Three-Month Outcomes Are Poor in Stroke Patients with Cancer Despite Acute Stroke Treatment"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0072-7248","authenticated-orcid":false,"given":"Shawna","family":"Cutting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Wettengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Conners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bichun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Busl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.0000000000000539","article-title":"Recurrent thromboembolic events after ischemic stroke in patients with cancer","volume":"83","author":"Navi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0015","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ejca.2012.01.005","article-title":"Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden","volume":"48","author":"Zoller","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0020","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1212\/01.WNL.0000129912.56486.2B","article-title":"Stroke in patients with cancer: incidence and etiology","volume":"62","author":"Cestari","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2008.01059.x","article-title":"Stroke and cancer: a review","volume":"119","author":"Grisold","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5853\/jos.2014.16.2.91","article-title":"Risk factors and biomarkers of ischemic stroke in cancer patients","volume":"16","author":"Kim","year":"2014","journal-title":"J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000097639","article-title":"Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study","volume":"23","author":"Zhang","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00415-015-7954-6","article-title":"Poor short-term outcome in patients with ischaemic stroke and active cancer","volume":"263","author":"Kneihsl","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0045","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/STROKEAHA.114.005784","article-title":"Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke","volume":"45","author":"Navi","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0050","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.11.003","article-title":"The activity of malignancy may determine stroke pattern in cancer patients","volume":"24","author":"Karlinska","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/STROKEAHA.109.571356","article-title":"Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea","volume":"41","author":"Kim","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0060","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1161\/STROKEAHA.112.658625","article-title":"Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology","volume":"43","author":"Schwarzbach","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","article-title":"Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study","volume":"44","author":"Rolfs","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0075","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00005792-198501000-00002","article-title":"Cerebrovascular complications in patients with cancer","volume":"64","author":"Graus","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0085","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-9343(87)90908-9","article-title":"Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation","volume":"83","author":"Rogers","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.neo.7900263","article-title":"The hypercoagulable state of malignancy: pathogenesis and current debate","volume":"4","author":"Caine","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10238-013-0230-0","article-title":"Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine","volume":"13","author":"Dammacco","year":"2013","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.24325","article-title":"Association between incident cancer and subsequent stroke","volume":"77","author":"Navi","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/ijs.12124","article-title":"Ischemic stroke in patients with cancer: is it different from usual strokes?","volume":"9","author":"Lee","year":"2014","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0115","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1161\/STROKEAHA.111.615534","article-title":"Lung cancer and incidence of stroke: a population-based cohort study","volume":"42","author":"Chen","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0120","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/bjc.2011.361","article-title":"Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study","volume":"105","author":"Chu","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0125","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jnci\/djp147","article-title":"Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma","volume":"101","author":"De Bruin","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejca.2004.11.013","article-title":"Increased incidence of stroke in women with breast cancer","volume":"41","author":"Nilsson","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-8-41","article-title":"Increased risk of ischemic stroke in cervical cancer patients: a nationwide population-based study","volume":"8","author":"Tsai","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0140","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.56.8.1015","article-title":"Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility","volume":"56","author":"Barber","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0145","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.STR.0000165902.18021.5b","article-title":"Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry","volume":"36","author":"Reeves","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0150","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1161\/STROKEAHA.111.644963","article-title":"Times from symptom onset to hospital arrival in the Get with the Guidelines\u2013Stroke Program 2002 to 2009: temporal trends and implications","volume":"43","author":"Tong","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0155","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","volume":"333","author":"NINDS","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.10.021_bib0160","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/01.STR.32.6.1330","article-title":"Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?","volume":"32","author":"Berger","year":"2001","journal-title":"Stroke"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716304232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716304232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T13:48:05Z","timestamp":1582552085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305716304232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1052305716304232"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.10.021","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}